Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Indivior ( (INDV) ).
On December 11, 2025, Indivior PLC shareholders approved amended articles of association to facilitate a scheme of arrangement. This scheme ensures that Indivior PLC becomes a wholly-owned subsidiary of Indivior Pharmaceuticals, Inc. The approval process included two shareholder meetings, with resolutions passed to authorize necessary actions for the scheme’s implementation. The scheme’s completion is pending a court sanction expected in January 2026.
The most recent analyst rating on (INDV) stock is a Hold with a $40.00 price target. To see the full list of analyst forecasts on Indivior stock, see the INDV Stock Forecast page.
Spark’s Take on INDV Stock
According to Spark, TipRanks’ AI Analyst, INDV is a Neutral.
Indivior’s overall score reflects strong earnings call outcomes and positive corporate events, which are offset by financial stability concerns and a high valuation. The technical analysis indicates bullish momentum, though caution is advised due to overbought signals.
To see Spark’s full report on INDV stock, click here.
More about Indivior
Average Trading Volume: 2,239,215
Technical Sentiment Signal: Buy
Current Market Cap: $4.44B
See more insights into INDV stock on TipRanks’ Stock Analysis page.